BHIC vs VERI: stock comparison and AI forecast
Bioscience Health Innovations, Inc. (BHIC) and Veritone, Inc. (VERI) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BHIC Bioscience Health Innovations, Inc.
- Market Cap
- $65M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
VERI Veritone, Inc.
- Price
- $0.48 -77.0% · 6M
- Market Cap
- $48M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- BHIC is 1.3 times larger than VERI by market capitalization ($65M against $48M).
- BHIC turns -14.7% of its revenue into net income, against -92.9% for VERI.
- VERI carries 2.92 times debt per unit of equity, against 0.16 times for BHIC.
- Both companies share the SEC industry classification Services-Computer Processing & Data Preparation.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BHIC | VERI |
|---|---|---|
| Market Cap | $65M | $48M |
| P/B Ratio | 35.16x | 1.27x |
| EPS | $0.00 | $-1.40 |
| Book Value/Share | $0.16 | $0.38 |
| Revenue/Share | $0.38 | – |
Profitability & Margins
| Metric | BHIC | VERI |
|---|---|---|
| ROE | -35.9% | -252.0% |
| ROA | -30.8% | -64.3% |
| ROIC | – | -159.9% |
| Gross Margin | 53.8% | 48.4% |
| Operating Margin | -13.7% | -74.6% |
| Net Margin | -14.7% | -92.9% |
| EBT Margin | -13.7% | -93.1% |
| Tax Rate | -7.3% | 0.3% |
Financial Health
| Metric | BHIC | VERI |
|---|---|---|
| Current Ratio | – | 0.47x |
| D/E Ratio | 0.16x | 2.92x |
| Financial Leverage | 1.16x | 3.92x |
| Interest Coverage | -9.2x | 81.4x |
| Working Capital | – | -$53M |
Cash Flow
| Metric | BHIC | VERI |
|---|---|---|
| Operating Cash Flow | -$2M | -$75M |
| OCF Growth YoY | -349.5% | – |
Operational Efficiency
| Metric | BHIC | VERI |
|---|---|---|
| Asset Turnover | 2.10x | – |
| Receivables Turnover | 11.3x | – |
| Inventory Turnover | 2.6x | – |
| Days Sales Outstanding | 32 days | – |
| Days Inventory | 140 days | – |
| Payables Period | 2 days | 230 days |
| Cash Conversion Cycle | 171 days | – |
Income Statement
| Metric | BHIC | VERI |
|---|---|---|
| Total Revenue | $4M | – |
| Operating Income | -$610K | -$77M |
| Net Income | -$660K | -$95M |
| R&D Expense | $230K | $22M |
| SG&A Expense | $2M | $104M |
| Cost of Goods Sold | $2M | $24M |
Dividend & Shareholder Information
| Metric | BHIC | VERI |
|---|---|---|
| Shares Outstanding | 12M | 100M |
| Net Income Growth | -169.2% | – |
| EPS Growth | -100.0% | – |
BHIC vs VERI: stock comparison and AI forecast
Which is bigger, BHIC or VERI?
BHIC is 1.3 times larger than VERI by market capitalization ($65M against $48M).
Which one does Intratio's AI model rank higher, BHIC or VERI?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.